PTK2 and hepatocellular carcinoma: These PROTACs have been tested on a panel of HCC (11 cell lines), tongue squamous cell carcinoma, melanoma, pancreatic ductal adenocarcinoma, and NSCL cancer cell lines, in which FAK is over-expressed.